Arunjyoti Bio

Market Cap: Micro Cap
Industry: Non Banking Financial Company (NBFC)
ISIN: INE485K01022
NSEID:
BSEID: 530881
View on BSE

INR

7.01

-0.06 (-0.85%)

BSENSE

Mar 20

BSE+NSE Vol: 70.2 k

{
  "main_header": {
    "sid": 685046,
    "name": "Arunjyoti Bio",
    "stock_name": "Arunjyoti Bio",
    "full_name": "Arunjyoti Bio Ventures Ltd",
    "name_url": "stocks-analysis/arunjyoti-bio",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.01",
    "chg": -0.06,
    "chgp": "-0.85%",
    "dir": -1,
    "prev_price": "7.07",
    "mcapval": "136.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530881,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE485K01022",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "70.2 k",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arunjyoti-bio-685046-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3892174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ArunjyotiBioVen_mojoScore_3892174.png",
        "date": "2026-03-15 10:10:12",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 15 March 2026, providing investors with the latest comprehensive view of the company’s position."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3866247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ArunjyotiBioVen_mojoScore_3866247.png",
        "date": "2026-03-03 10:10:23",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3848222",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ArunjyotiBioVen_mojoScore_3848222.png",
        "date": "2026-02-20 10:10:20",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 20 February 2026, providing investors with the latest comprehensive view of the company’s position."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3828441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ArunjyotiBioVen_mojoScore_3828441.png",
        "date": "2026-02-09 10:10:52",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Arunjyoti Bio Ventures Gains 10.04%: Key Financial Trends and Market Moves This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arunjyoti-bio-ventures-gains-1004-key-financial-trends-and-market-moves-this-week-3826432",
        "imagepath": "",
        "date": "2026-02-07 16:03:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at Rs.7.16, up 1.27% despite Sensex decline</p>\n                    <p><strong>3 Feb:</strong> Q3 FY26 results reveal profitability pressures; stock dips 1.26%</p>\n                    <p><strong>4 Feb:</strong> Flat quarterly performance reported; stock rebounds 4.10%</p>\n                    <p><strong>5 Feb:</strong> Strong volume supports 1.90% gain amid mixed market</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.7.78, up 3.73% on positive momentum</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n        ..."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd Reports Flat Quarterly Performance Amid Mixed Long-Term Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arunjyoti-bio-ventures-ltd-reports-flat-quarterly-performance-amid-mixed-long-term-returns-3819454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ArunjyotiBioVen_fintrenddot_3819454.png",
        "date": "2026-02-04 08:00:16",
        "description": "Arunjyoti Bio Ventures Ltd, a player in the Non Banking Financial Company (NBFC) sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. Despite this, the company’s long-term returns remain highly volatile, with recent downgrades reflecting cautious investor sentiment amid sector challenges."
      },
      {
        "title": "Are Arunjyoti Bio Ventures Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-arunjyoti-bio-ventures-ltd-latest-results-good-or-bad-3818970",
        "imagepath": "",
        "date": "2026-02-03 19:20:40",
        "description": "Arunjyoti Bio Ventures Ltd has reported its financial results for the nine-month period ending FY26, indicating a net profit of ₹0.87 crores, which reflects a positive year-on-year performance. However, the company's operational metrics reveal significant volatility and modest scale, with historical quarterly revenues consistently below ₹0.25 crores. \n\nIn the latest quarter ending December 2025, the company experienced a quarter-on-quarter growth in net sales of 21.16%, a notable recovery from the previous quarter's decline. Additionally, the standalone net profit showed a substantial increase of 104.07% compared to the prior quarter, indicating an improvement in profitability metrics. The operating profit margin, excluding other income, also demonstrated a positive trend, rising to 21.95%.\n\nDespite these improvements, the company faces challenges, including a high price-to-book value of 3.94x, which sugges..."
      },
      {
        "title": "Arunjyoti Bio Ventures Q3 FY26: Micro-Cap NBFC Faces Profitability Pressures Amid Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/arunjyoti-bio-ventures-q3-fy26-micro-cap-nbfc-faces-profitability-pressures-amid-valuation-concerns-3818897",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ArunjyotiBioVen_quaterlyResult_3818897.png",
        "date": "2026-02-03 17:46:37",
        "description": "Arunjyoti Bio Ventures Limited, a micro-cap non-banking financial company with a market capitalisation of ₹133.00 crores, is navigating challenging waters as the company transitions from its historical co-packing operations to financial services. Trading at ₹7.30 per share, the stock has declined 49.66% over the past year, significantly underperforming the Sensex's 8.49% gain during the same period. With a \"Very Expensive\" valuation grade and deteriorating financial trends, the company faces mounting pressure to demonstrate sustainable profitability and operational clarity."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd Forms Death Cross, Signalling Bearish Trend Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arunjyoti-bio-ventures-ltd-forms-death-cross-signalling-bearish-trend-ahead-3811784",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ArunjyotiBioVen_dealthcross_3811784.png",
        "date": "2026-01-30 18:00:40",
        "description": "Arunjyoti Bio Ventures Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about sustained bearish momentum in the near to medium term."
      }
    ],
    "total": 341,
    "sid": "685046",
    "stock_news_url": "https://www.marketsmojo.com/news/arunjyoti-bio-ventures-685046"
  },
  "announcements": [
    {
      "caption": "Intimation Of Installation And Commissioning Of New Jelly Pouch Production Line",
      "datetime": "10-Mar-2026",
      "details": "Intimation of Installation and commisioning of New Jelly Pouch Production Line",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results Along With Limited Review Report For The Quarter Ended 31.12.2025.",
      "datetime": "03-Feb-2026",
      "details": "Unauited Financial Results along with Limited Review Report for the quarter ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 03.02.2026",
      "datetime": "03-Feb-2026",
      "details": "Approval of Un-audited financial results along with the Limited Review Report for the quarter ended 31.12.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Arunjyoti Bio Ventures Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Jan 25",
          "dt": "2025-01-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Arunjyoti Bio Ventures Ltd is Rated Strong Sell

2026-03-15 10:10:12

Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 15 March 2026, providing investors with the latest comprehensive view of the company’s position.

Read full news article

Arunjyoti Bio Ventures Ltd is Rated Strong Sell

2026-03-03 10:10:23

Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Arunjyoti Bio Ventures Ltd is Rated Strong Sell

2026-02-20 10:10:20

Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 20 February 2026, providing investors with the latest comprehensive view of the company’s position.

Read full news article

Arunjyoti Bio Ventures Ltd is Rated Strong Sell

2026-02-09 10:10:52

Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Arunjyoti Bio Ventures Gains 10.04%: Key Financial Trends and Market Moves This Week

2026-02-07 16:03:24

Key Events This Week

2 Feb: Stock opens at Rs.7.16, up 1.27% despite Sensex decline

3 Feb: Q3 FY26 results reveal profitability pressures; stock dips 1.26%

4 Feb: Flat quarterly performance reported; stock rebounds 4.10%

5 Feb: Strong volume supports 1.90% gain amid mixed market

6 Feb: Week closes at Rs.7.78, up 3.73% on positive momentum

Week Open

...

Read full news article

Arunjyoti Bio Ventures Ltd Reports Flat Quarterly Performance Amid Mixed Long-Term Returns

2026-02-04 08:00:16

Arunjyoti Bio Ventures Ltd, a player in the Non Banking Financial Company (NBFC) sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. Despite this, the company’s long-term returns remain highly volatile, with recent downgrades reflecting cautious investor sentiment amid sector challenges.

Read full news article

Are Arunjyoti Bio Ventures Ltd latest results good or bad?

2026-02-03 19:20:40

Arunjyoti Bio Ventures Ltd has reported its financial results for the nine-month period ending FY26, indicating a net profit of ₹0.87 crores, which reflects a positive year-on-year performance. However, the company's operational metrics reveal significant volatility and modest scale, with historical quarterly revenues consistently below ₹0.25 crores. In the latest quarter ending December 2025, the company experienced a quarter-on-quarter growth in net sales of 21.16%, a notable recovery from the previous quarter's decline. Additionally, the standalone net profit showed a substantial increase of 104.07% compared to the prior quarter, indicating an improvement in profitability metrics. The operating profit margin, excluding other income, also demonstrated a positive trend, rising to 21.95%. Despite these improvements, the company faces challenges, including a high price-to-book value of 3.94x, which sugges...

Read full news article

Arunjyoti Bio Ventures Q3 FY26: Micro-Cap NBFC Faces Profitability Pressures Amid Valuation Concerns

2026-02-03 17:46:37

Arunjyoti Bio Ventures Limited, a micro-cap non-banking financial company with a market capitalisation of ₹133.00 crores, is navigating challenging waters as the company transitions from its historical co-packing operations to financial services. Trading at ₹7.30 per share, the stock has declined 49.66% over the past year, significantly underperforming the Sensex's 8.49% gain during the same period. With a "Very Expensive" valuation grade and deteriorating financial trends, the company faces mounting pressure to demonstrate sustainable profitability and operational clarity.

Read full news article

Arunjyoti Bio Ventures Ltd Forms Death Cross, Signalling Bearish Trend Ahead

2026-01-30 18:00:40

Arunjyoti Bio Ventures Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about sustained bearish momentum in the near to medium term.